Syndax Pharmaceuticals, Inc. SNDX
Set alert
13.10 USD -0.55 -4.03%
At close
13.00 -0.10 -0.76%
Pre-market · Nov 3, 4:20 AM ET
12.90 Day range 13.75
12.80 52-week range 25.59
- YTD
- -37.65%
- 1 year
- -4.38%
- Open
- 13.62
- Prev close
- 13.65
- Mkt cap
- 1.17B
- Vol
- 3.18M
- Avg vol
- 1.96M
- EPS
- -2.52
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 12.90
- High
- 13.75
- Forward P/E
- -17.89
- Beta
- 0.45
- Short ratio
- 8.03
- Inst. own
- 126.78%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 2, 2026
- 50-d avg
- 17.18
- 200-d avg
- 20.23
- 1y target
- 37.27
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 37.27 +184.5% upside
Now 13.10
- Target (low)
- 23.00
- Target (mean)
- 37.27
- Target (high)
- 57.00
Ratings (0m) 12 12 buy · 0 hold · 0 sell
- Strong buy2
- Buy10
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 12
- 2 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.48378 | -0.58 – -0.375 | -0.70 | +30.9% | 81.81M | +78.3% | 11 |
| Next quarter | -0.45558 | -0.60127 – -0.27 | -0.78 | +41.6% | 96.00M | +39.7% | 11 |
| Current year | -1.95 | -2.25 – -1.60 | -3.29 | +40.7% | 314.09M | +82.2% | 11 |
| Next year | -0.73205 | -1.96 – 0.39865 | -1.95 | +62.5% | 459.25M | +46.2% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 21, 2026 | UBS | Maintained | Buy | Buy |
| Aug 11, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 5, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 15, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 12, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 22, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 13, 2026 | UBS | Maintained | Buy | Buy |
| May 1, 2026 | Barclays | Maintained | Overweight | Overweight |
| Apr 1, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Mar 31, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Mar 9, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Mar 2, 2026 | Citigroup | Maintained | Buy | Buy |
| Dec 9, 2025 | BTIG | Reiterated | Buy | Buy |
| Nov 24, 2025 | Barclays | Maintained | Overweight | Overweight |
| Nov 12, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 4, 2025 | UBS | Maintained | Buy | Buy |
| Nov 4, 2025 | Barclays | Maintained | Overweight | Overweight |
| Oct 27, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 27, 2025 | BTIG | Reiterated | Buy | Buy |
| Sep 19, 2025 | BTIG | Reiterated | Buy | Buy |
| Sep 5, 2025 | Goldman Sachs | Maintained | Buy | Buy |
| Sep 4, 2025 | Guggenheim | Initiated | — | Buy |
| Aug 5, 2025 | Citigroup | Maintained | Buy | Buy |
| Aug 5, 2025 | BTIG | Maintained | Buy | Buy |
| Jul 15, 2025 | UBS | Maintained | Buy | Buy |
| Jul 10, 2025 | Goldman Sachs | Initiated | — | Buy |
| May 6, 2025 | Scotiabank | Maintained | Sector Perform | Sector Perform |
| May 6, 2025 | Guggenheim | Reiterated | Buy | Buy |
| Mar 20, 2025 | JP Morgan | Maintained | Overweight | Overweight |